Healthcare Sector Stocks
The Healthcare sector has a total of 1050 stocks, with a combined market cap of $9.87 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 46.29.
Market Cap
9.87T
Revenue
4.74T
Profits
213.28B
PE Ratio
46.29
Profit Margin
4.50%
Dividend Yield
0.38%
1050 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.21T | -0.13% | 1,054,530 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 657.80B | 0.34% | 1,873,029 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 511.70B | 0.43% | 1,012,656 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 361.38B | -0.24% | 2,202,972 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 350.37B | -1.19% | 1,811,704 | 450.06B |
| 6 | NVS | Novartis AG | 311.05B | 0.09% | 913,782 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 292.35B | -0.36% | 1,250,049 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 254.44B | 1.44% | 534,415 | 47.35B |
| 9 | AMGN | Amgen Inc. | 249.50B | 0.21% | 607,278 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 207.94B | 0.05% | 1,033,480 | 30.99B |
| 11 | ABT | Abbott Laboratories | 192.64B | -2.09% | 1,717,366 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 179.52B | -0.02% | 3,598,849 | 50.70B |
| 13 | PFE | Pfizer Inc. | 167.06B | -0.48% | 19,909,973 | 63.62B |
| 14 | DHR | Danaher Corporation | 160.07B | 0.53% | 732,416 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 158.76B | -2.25% | 628,941 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 138.57B | 0.75% | 294,251 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.57B | -1.14% | 1,922,616 | 50.03B |
| 18 | MDT | Medtronic plc | 125.49B | -2.22% | 2,073,919 | 37.54B |
| 19 | SYK | Stryker Corporation | 124.54B | -2.37% | 916,111 | 26.30B |
| 20 | MCK | McKesson Corporation | 121.88B | -1.53% | 213,376 | 418.79B |
| 21 | SNY | Sanofi | 112.84B | -0.71% | 1,056,768 | 57.89B |
| 22 | CVS | CVS Health Corporation | 107.18B | 3.00% | 4,834,984 | 418.16B |
| 23 | MRNA | Moderna, Inc. | 105.59B | 9.54% | 9,073,268 | 2.53B |
| 24 | HCA | HCA Healthcare, Inc. | 103.23B | -2.62% | 366,949 | 78.70B |
| 25 | GSK | GSK plc | 101.89B | -0.18% | 894,686 | 44.53B |
| 26 | ELV | Elevance Health, Inc. | 91.99B | -1.44% | 361,892 | 201.83B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 90.31B | -0.32% | 269,475 | 16.90B |
| 28 | CI | The Cigna Group | 77.43B | -2.53% | 532,841 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 65.73B | -0.94% | 864,473 | 29.86B |
| 30 | COR | Cencora, Inc. | 63.73B | -1.68% | 310,331 | 337.40B |
| 31 | BSX | Boston Scientific Corporation | 62.70B | -3.10% | 3,493,875 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 61.60B | -0.48% | 331,365 | 257.75B |
| 33 | BDX | Becton, Dickinson and Company | 58.34B | 0.29% | 617,550 | 19.46B |
| 34 | EW | Edwards Lifesciences Corporation | 58.01B | 0.06% | 1,069,405 | 6.67B |
| 35 | ARGX | argenx SE | 57.71B | 0.81% | 124,635 | 5.92B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 52.91B | 0.13% | 110,236 | 4.66B |
| 37 | MDLN | Medline Inc. | 51.31B | -1.89% | 1,688,572 | 30.68B |
| 38 | HUM | Humana Inc. | 51.07B | 3.28% | 906,011 | 154.19B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 49.26B | 1.05% | 1,993,803 | 17.23B |
| 40 | VEEV | Veeva Systems Inc. | 48.96B | -2.49% | 460,023 | 3.46B |
| 41 | A | Agilent Technologies, Inc. | 48.90B | 0.97% | 361,777 | 7.37B |
| 42 | ONC | BeOne Medicines AG | 46.28B | 5.10% | 448,341 | 6.61B |
| 43 | WAT | Waters Corporation | 45.22B | 1.59% | 148,354 | 5.61B |
| 44 | NTRA | Natera, Inc. | 44.32B | -15.47% | 2,431,395 | 2.91B |
| 45 | IQV | IQVIA Holdings Inc. | 44.30B | 1.49% | 295,343 | 17.31B |
| 46 | RVMD | Revolution Medicines, Inc. | 40.66B | 5.83% | 1,273,971 | 197.56M |
| 47 | HLN | Haleon plc | 40.07B | -0.71% | 8,977,283 | 14.80B |
| 48 | RPRX | Royalty Pharma plc | 38.89B | 0.34% | 714,737 | 2.62B |
| 49 | GEHC | GE HealthCare Technologies Inc. | 37.43B | -1.16% | 1,101,056 | 21.64B |
| 50 | BIIB | Biogen Inc. | 36.65B | 1.65% | 209,414 | 10.30B |
| 51 | ALC | Alcon Inc. | 36.49B | -1.99% | 946,253 | 10.86B |
| 52 | MTD | Mettler-Toledo International Inc. | 34.76B | 3.32% | 82,137 | 4.20B |
| 53 | CNC | Centene Corporation | 34.39B | -6.35% | 1,118,229 | 180.41B |
| 54 | GMAB | Genmab A/S | 34.36B | -0.53% | 2,326,049 | 4.30B |
| 55 | RMD | ResMed Inc. | 33.18B | -1.44% | 380,480 | 5.73B |
| 56 | ZTS | Zoetis Inc. | 32.98B | -2.80% | 1,579,936 | 9.52B |
| 57 | ILMN | Illumina, Inc. | 31.82B | 1.16% | 642,641 | 4.54B |
| 58 | DXCM | DexCom, Inc. | 30.10B | -4.43% | 736,105 | 5.10B |
| 59 | PHG | Koninklijke Philips N.V. | 29.96B | -0.72% | 727,765 | 20.16B |
| 60 | LH | Labcorp Holdings Inc. | 29.61B | 0.36% | 85,292 | 14.59B |
| 61 | DGX | Quest Diagnostics Incorporated | 28.02B | -0.04% | 191,632 | 11.84B |
| 62 | WST | West Pharmaceutical Services, Inc. | 27.74B | 1.45% | 138,447 | 3.40B |
| 63 | ROIV | Roivant Sciences Ltd. | 27.55B | 4.16% | 3,350,800 | 7.53M |
| 64 | STE | STERIS plc | 24.56B | -0.89% | 203,023 | 6.17B |
| 65 | INSM | Insmed Incorporated | 24.32B | 1.95% | 520,762 | 1.52B |
| 66 | INCY | Incyte Corporation | 24.11B | 0.25% | 309,761 | 6.01B |
| 67 | UTHR | United Therapeutics Corporation | 24.07B | -0.09% | 145,290 | 3.19B |
| 68 | THC | Tenet Healthcare Corporation | 22.43B | -1.62% | 121,862 | 22.15B |
| 69 | VTRS | Viatris Inc. | 22.10B | 1.63% | 2,420,042 | 14.73B |
| 70 | BNTX | BioNTech SE | 21.52B | 1.09% | 226,024 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.02B | 0.16% | 883,136 | 5.01B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 20.11B | -0.53% | 452,229 | 8.57B |
| 73 | GH | Guardant Health, Inc. | 19.58B | -5.26% | 2,606,518 | 1.28B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.10B | 1.88% | 45,275 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.40B | 3.36% | 565,192 | 2.94B |
| 76 | ASND | Ascendis Pharma A/S | 16.75B | 0.61% | 155,953 | 1.20B |
| 77 | EXEL | Exelixis, Inc. | 16.70B | -0.39% | 507,244 | 2.50B |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 16.51B | 2.07% | 356,676 | 3.70B |
| 79 | CRL | Charles River Laboratories International, Inc. | 15.84B | 5.64% | 194,641 | 3.98B |
| 80 | SOLV | Solventum Corporation | 15.52B | 4.60% | 1,003,111 | 8.16B |
| 81 | ICLR | ICON Public Limited Company | 15.22B | 0.74% | 357,448 | 8.23B |
| 82 | JAZZ | Jazz Pharmaceuticals plc | 15.12B | 3.62% | 175,634 | 4.72B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 14.61B | 0.97% | 820,551 | 945.54M |
| 84 | BTSG | BrightSpring Health Services, Inc. | 13.56B | -1.18% | 583,466 | 15.25B |
| 85 | EHC | Encompass Health Corporation | 13.47B | -2.81% | 242,077 | 6.34B |
| 86 | GKOS | Glaukos Corporation | 13.38B | 2.78% | 308,055 | 690.33M |
| 87 | BAX | Baxter International Inc. | 13.18B | -0.66% | 986,215 | 11.61B |
| 88 | TEM | Tempus AI, Inc. | 13.17B | 2.50% | 2,365,919 | 1.51B |
| 89 | SNN | Smith & Nephew plc | 12.94B | -2.97% | 830,837 | 6.30B |
| 90 | PEN | Penumbra, Inc. | 12.64B | -0.13% | 69,115 | 1.56B |
| 91 | ELAN | Elanco Animal Health Incorporated | 12.62B | 6.63% | 3,907,440 | 5.15B |
| 92 | SMMT | Summit Therapeutics Inc. | 12.48B | 10.01% | 1,703,676 | - |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 12.31B | 1.86% | 612,965 | 3.44B |
| 94 | FMS | Fresenius Medical Care AG | 12.17B | -1.23% | 313,207 | 22.12B |
| 95 | HALO | Halozyme Therapeutics, Inc. | 11.97B | -14.23% | 2,811,155 | 1.80B |
| 96 | DVA | DaVita Inc. | 11.96B | -2.45% | 116,748 | 14.17B |
| 97 | COO | The Cooper Companies, Inc. | 11.93B | -1.18% | 351,613 | 4.24B |
| 98 | ALGN | Align Technology, Inc. | 11.53B | 2.60% | 426,735 | 4.16B |
| 99 | UHS | Universal Health Services, Inc. | 11.49B | -1.82% | 96,997 | 18.35B |
| 100 | TECH | Bio-Techne Corporation | 11.41B | 0.12% | 1,065,767 | 1.22B |
| 101 | KYMR | Kymera Therapeutics, Inc. | 11.06B | 1.08% | 182,122 | 102.24M |
| 102 | RGEN | Repligen Corporation | 10.95B | 1.69% | 303,195 | 805.61M |
| 103 | BMRN | BioMarin Pharmaceutical Inc. | 10.84B | -0.29% | 484,145 | 3.66B |
| 104 | MOH | Molina Healthcare, Inc. | 10.82B | -4.08% | 142,831 | 42.08B |
| 105 | ENSG | The Ensign Group, Inc. | 10.42B | -1.26% | 54,843 | 5.67B |
| 106 | QGEN | Qiagen N.V. | 10.41B | -0.87% | 1,638,263 | 2.12B |
| 107 | AVTR | Avantor, Inc. | 10.41B | 1.45% | 1,090,877 | 6.64B |
| 108 | BIO | Bio-Rad Laboratories, Inc. | 10.21B | 2.84% | 60,431 | 2.59B |
| 109 | PODD | Insulet Corporation | 10.08B | -6.90% | 417,229 | 3.19B |
| 110 | PCVX | Vaxcyte, Inc. | 10.03B | 2.28% | 279,676 | - |
| 111 | GMED | Globus Medical, Inc. | 9.64B | -11.82% | 3,018,187 | 3.14B |
| 112 | HSIC | Henry Schein, Inc. | 9.59B | 1.75% | 324,456 | 13.73B |
| 113 | SYRE | Spyre Therapeutics, Inc. | 9.50B | 3.58% | 329,641 | - |
| 114 | OSCR | Oscar Health, Inc. | 9.48B | -7.32% | 2,277,112 | 17.47B |
| 115 | BRKR | Bruker Corporation | 9.16B | 3.50% | 531,779 | 3.51B |
| 116 | HNGE | Hinge Health, Inc. | 9.10B | -2.73% | 416,156 | 800.82M |
| 117 | ATR | AptarGroup, Inc. | 9.03B | -1.07% | 94,897 | 3.99B |
| 118 | KRYS | Krystal Biotech, Inc. | 8.97B | 0.82% | 36,213 | 470.03M |
| 119 | MDGL | Madrigal Pharmaceuticals, Inc. | 8.96B | -3.60% | 454,569 | 1.43B |
| 120 | IBRX | ImmunityBio, Inc. | 8.65B | 1.87% | 2,696,271 | 165.79M |
| 121 | HQY | HealthEquity, Inc. | 8.53B | -0.31% | 123,122 | 1.36B |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.48B | -3.16% | 423,034 | 551.69M |
| 123 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.24B | 1.46% | 326,194 | 669.50M |
| 124 | TGTX | TG Therapeutics, Inc. | 8.23B | 0.03% | 451,394 | 799.54M |
| 125 | CORT | Corcept Therapeutics Incorporated | 7.98B | 1.79% | 244,469 | 963.65M |
| 126 | CYTK | Cytokinetics, Incorporated | 7.81B | 1.19% | 674,329 | 113.29M |
| 127 | PACS | PACS Group, Inc. | 7.78B | -2.41% | 224,216 | 5.71B |
| 128 | ABVX | ABIVAX Société Anonyme | 7.66B | 0.84% | 245,432 | 5.33M |
| 129 | ALKS | Alkermes plc | 7.62B | 1.86% | 212,891 | 1.75B |
| 130 | GRFS | Grifols, S.A. | 7.53B | - | 211,840 | 8.63B |
| 131 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.51B | 3.13% | 2,160,258 | 280.75M |
| 132 | PRAX | Praxis Precision Medicines, Inc. | 7.49B | 2.17% | 71,346 | 7.46M |
| 133 | TXG | 10x Genomics, Inc. | 7.49B | -0.98% | 1,760,408 | 618.58M |
| 134 | TWST | Twist Bioscience Corporation | 7.48B | -1.14% | 744,720 | 431.80M |
| 135 | BLCO | Bausch + Lomb Corporation | 7.14B | 0.30% | 82,944 | 5.42B |
| 136 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.13B | 2.79% | 112,104 | 945.96M |
| 137 | AXSM | Axsome Therapeutics, Inc. | 6.99B | 2.31% | 123,079 | 865.27M |
| 138 | CAI | Caris Life Sciences, Inc. | 6.98B | -6.45% | 3,111,942 | 1.05B |
| 139 | AMRX | Amneal Pharmaceuticals, Inc. | 6.95B | 2.57% | 354,470 | 3.20B |
| 140 | CGON | CG Oncology, Inc. | 6.93B | 20.60% | 675,293 | 6.17M |
| 141 | CHE | Chemed Corporation | 6.82B | -1.46% | 58,931 | 2.66B |
| 142 | ORKA | Oruka Therapeutics, Inc. | 6.67B | 4.91% | 127,967 | - |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.03% | 282,793 | 1.56B |
| 144 | IONS | Ionis Pharmaceuticals, Inc. | 6.55B | 1.52% | 409,572 | 874.09M |
| 145 | IMVT | Immunovant, Inc. | 6.12B | 4.44% | 545,313 | - |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 6.10B | 2.00% | 32,426 | 253.83M |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 6.08B | -0.46% | 342,988 | 670.78M |
| 148 | KOD | Kodiak Sciences Inc. | 6.06B | 6.19% | 152,307 | - |
| 149 | TFX | Teleflex Incorporated | 5.99B | -0.78% | 206,128 | 2.26B |
| 150 | RDNT | RadNet, Inc. | 5.93B | -3.41% | 175,481 | 2.27B |
| 151 | BLTE | Belite Bio, Inc | 5.91B | 2.57% | 54,502 | - |
| 152 | HIMS | Hims & Hers Health, Inc. | 5.91B | 5.24% | 6,198,589 | 2.58B |
| 153 | DOCS | Doximity, Inc. | 5.68B | -3.95% | 1,809,285 | 661.58M |
| 154 | SRRK | Scholar Rock Holding Corporation | 5.67B | 2.26% | 310,788 | - |
| 155 | MANE | Veradermics, Incorporated | 5.64B | 4.98% | 131,550 | - |
| 156 | SUPN | Supernus Pharmaceuticals, Inc. | 5.58B | 0.50% | 579,062 | 1.37B |
| 157 | PTCT | PTC Therapeutics, Inc. | 5.55B | 1.16% | 131,338 | 1.16B |
| 158 | CON | Concentra Group Holdings Parent, Inc. | 5.39B | 0.25% | 382,652 | 2.34B |
| 159 | WAY | Waystar Holding Corp. | 5.39B | -3.08% | 226,328 | 1.26B |
| 160 | HAE | Haemonetics Corporation | 5.38B | -4.67% | 153,484 | 1.38B |
| 161 | GRAL | GRAIL, Inc. | 5.32B | -0.21% | 347,170 | 166.60M |
| 162 | LFST | LifeStance Health Group, Inc. | 5.28B | 3.43% | 1,399,310 | 1.68B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.26B | -2.09% | 69,800 | 1.61B |
| 164 | COGT | Cogent Biosciences, Inc. | 5.21B | 1.39% | 340,479 | - |
| 165 | BLLN | BillionToOne, Inc. | 5.15B | -2.96% | 272,779 | 436.87M |
| 166 | LIVN | LivaNova PLC | 4.98B | -0.76% | 44,669 | 1.51B |
| 167 | MMED | MiniMed Group, Inc. | 4.92B | -3.77% | 1,726,519 | 3.22B |
| 168 | CRSP | CRISPR Therapeutics AG | 4.83B | 2.45% | 416,598 | 25.17M |
| 169 | ERAS | Erasca, Inc. | 4.78B | 3.01% | 866,697 | - |
| 170 | TVTX | Travere Therapeutics, Inc. | 4.77B | 1.76% | 264,992 | 651.03M |
| 171 | OPCH | Option Care Health, Inc. | 4.74B | 0.40% | 347,578 | 5.75B |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.73B | 11.11% | 595,293 | - |
| 173 | DNTH | Dianthus Therapeutics, Inc. | 4.72B | 0.99% | 124,338 | 2.72M |
| 174 | SHC | Sotera Health Company | 4.52B | -0.19% | 426,839 | 1.23B |
| 175 | HTFL | HeartFlow, Inc. | 4.49B | -0.64% | 211,992 | 212.07M |
| 176 | LEGN | Legend Biotech Corporation | 4.45B | 2.00% | 569,881 | 1.27B |
| 177 | ADPT | Adaptive Biotechnologies Corporation | 4.38B | 0.86% | 1,276,235 | 298.01M |
| 178 | DFTX | Definium Therapeutics, Inc. | 4.34B | 6.46% | 316,208 | - |
| 179 | ICUI | ICU Medical, Inc. | 4.31B | 2.85% | 138,666 | 2.18B |
| 180 | ITGR | Integer Holdings Corporation | 4.31B | -0.07% | 164,284 | 1.83B |
| 181 | CDNA | CareDx, Inc. | 4.05B | 1.06% | 424,519 | 497.40M |
| 182 | NVST | Envista Holdings Corporation | 4.01B | 0.12% | 787,431 | 2.88B |
| 183 | LQDA | Liquidia Corporation | 3.98B | - | 308,785 | 450.91M |
| 184 | RLAY | Relay Therapeutics, Inc. | 3.91B | 4.91% | 603,865 | 10.35M |
| 185 | ABCL | AbCellera Biologics Inc. | 3.80B | 5.30% | 777,457 | 66.17M |
| 186 | XENE | Xenon Pharmaceuticals Inc. | 3.68B | 0.93% | 126,794 | 7.50M |
| 187 | STVN | Stevanato Group S.p.A. | 3.65B | 1.06% | 370,110 | 1.42B |
| 188 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.63B | 4.71% | 224,476 | -665.00K |
| 189 | ACAD | Acadia Pharmaceuticals Inc. | 3.63B | -1.18% | 348,133 | 1.20B |
| 190 | OGN | Organon & Co. | 3.63B | 0.15% | 513,492 | 6.10B |
| 191 | PLSE | Pulse Biosciences, Inc. | 3.62B | -4.28% | 126,816 | 1.49M |
| 192 | TNGX | Tango Therapeutics, Inc. | 3.61B | 2.64% | 275,302 | 53.81M |
| 193 | IOVA | Iovance Biotherapeutics, Inc. | 3.59B | 2.45% | 4,131,699 | 378.98M |
| 194 | IRON | Disc Medicine, Inc. | 3.52B | 1.04% | 82,189 | - |
| 195 | ELVN | Enliven Therapeutics, Inc. | 3.51B | 6.85% | 229,741 | - |
| 196 | PBLS | Parabilis Medicines, Inc. | 3.44B | -0.14% | 109,561 | 148.00K |
| 197 | DYN | Dyne Therapeutics, Inc. | 3.41B | 5.07% | 376,325 | - |
| 198 | ACHC | Acadia Healthcare Company, Inc. | 3.38B | 4.54% | 1,019,107 | 3.41B |
| 199 | TARS | Tarsus Pharmaceuticals, Inc. | 3.37B | 1.32% | 93,294 | 682.20M |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.37B | 2.48% | 795,502 | - |
| 201 | WRBY | Warby Parker Inc. | 3.34B | 3.34% | 875,276 | 934.66M |
| 202 | TLX | Telix Pharmaceuticals Limited | 3.31B | 2.44% | 149,803 | 890.79M |
| 203 | ARQT | Arcutis Biotherapeutics, Inc. | 3.27B | -4.11% | 1,107,896 | 508.68M |
| 204 | VRDN | Viridian Therapeutics, Inc. | 3.27B | 0.84% | 1,871,546 | 26.31M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.21B | 1.62% | 381,286 | 21.38M |
| 206 | NHC | National HealthCare Corporation | 3.21B | -1.38% | 107,655 | 1.58B |
| 207 | CELC | Celcuity Inc. | 3.17B | 1.23% | 285,539 | - |
| 208 | PRVA | Privia Health Group, Inc. | 3.08B | 0.79% | 774,314 | 2.43B |
| 209 | ZLAB | Zai Lab Limited | 3.03B | 8.10% | 523,808 | 441.73M |
| 210 | ATRC | AtriCure, Inc. | 3.03B | -3.05% | 106,981 | 589.80M |
| 211 | SGRY | Surgery Partners, Inc. | 3.01B | 0.15% | 1,008,423 | 3.37B |
| 212 | IDYA | IDEAYA Biosciences, Inc. | 3.00B | 1.21% | 241,523 | 36.54M |
| 213 | BHC | Bausch Health Companies Inc. | 2.99B | 0.50% | 703,457 | 11.11B |
| 214 | TMDX | TransMedics Group, Inc. | 2.94B | 22.77% | 1,191,218 | 727.65M |
| 215 | AXGN | Axogen, Inc. | 2.90B | -0.51% | 130,822 | 266.93M |
| 216 | IRTC | iRhythm Holdings, Inc. | 2.89B | -32.58% | 2,381,317 | 854.04M |
| 217 | ADMA | ADMA Biologics, Inc. | 2.85B | -2.88% | 1,430,426 | 519.15M |
| 218 | AVAH | Aveanna Healthcare Holdings Inc. | 2.83B | -4.97% | 509,532 | 2.60B |
| 219 | VCEL | Vericel Corporation | 2.68B | 1.26% | 501,751 | 324.17M |
| 220 | GRDN | Guardian Pharmacy Services, Inc. | 2.66B | 5.44% | 447,294 | 1.46B |
| 221 | XNCR | Xencor, Inc. | 2.63B | 3.02% | 172,917 | 200.49M |
| 222 | BEAM | Beam Therapeutics Inc. | 2.63B | 1.87% | 462,350 | 146.64M |
| 223 | XERS | Xeris Biopharma Holdings, Inc. | 2.62B | 9.82% | 2,543,646 | 368.26M |
| 224 | RCUS | Arcus Biosciences, Inc. | 2.61B | 2.66% | 152,860 | 100.00M |
| 225 | NEOG | Neogen Corporation | 2.57B | 0.94% | 517,533 | 884.00M |
| 226 | RGC | Regencell Bioscience Holdings Limited | 2.57B | -1.52% | 72,504 | - |
| 227 | HCM | HUTCHMED (China) Limited | 2.56B | 4.12% | 32,751 | 549.12M |
| 228 | PGNY | Progyny, Inc. | 2.55B | -0.70% | 328,053 | 1.34B |
| 229 | MBX | MBX Biosciences, Inc. | 2.43B | 3.92% | 75,644 | - |
| 230 | PHVS | Pharvaris N.V. | 2.40B | 5.23% | 115,629 | - |
| 231 | ARDT | Ardent Health, Inc. | 2.40B | 7.23% | 783,038 | 6.45B |
| 232 | MD | Pediatrix Medical Group, Inc. | 2.39B | -1.48% | 101,109 | 1.96B |
| 233 | PVLA | Palvella Therapeutics, Inc. | 2.38B | 5.20% | 50,148 | - |
| 234 | CLOV | Clover Health Investments, Corp. | 2.35B | -1.56% | 2,609,584 | 2.74B |
| 235 | UFPT | UFP Technologies, Inc. | 2.31B | -0.61% | 21,840 | 649.52M |
| 236 | NAMS | NewAmsterdam Pharma Company N.V. | 2.31B | 2.12% | 427,761 | 25.94M |
| 237 | SEPN | Septerna, Inc. | 2.30B | 3.93% | 47,353 | 98.88M |
| 238 | ADUS | Addus HomeCare Corporation | 2.28B | -1.54% | 71,233 | 1.50B |
| 239 | CLDX | Celldex Therapeutics, Inc. | 2.27B | 2.33% | 250,441 | 158.00K |
| 240 | COAG | Hemab Therapeutics Holdings, Inc. | 2.24B | 5.33% | 123,548 | - |
| 241 | SDGR | Schrödinger, Inc. | 2.23B | 3.23% | 515,263 | 269.20M |
| 242 | VERA | Vera Therapeutics, Inc. | 2.20B | 1.09% | 729,676 | 10.28M |
| 243 | RXRX | Recursion Pharmaceuticals, Inc. | 2.20B | 0.71% | 6,041,587 | 68.23M |
| 244 | AUPH | Aurinia Pharmaceuticals Inc. | 2.19B | 0.62% | 216,402 | 321.74M |
| 245 | PRGO | Perrigo Company plc | 2.17B | -0.51% | 319,082 | 4.09B |
| 246 | IMNM | Immunome, Inc. | 2.16B | 2.43% | 343,357 | 4.02M |
| 247 | BKD | Brookdale Senior Living Inc. | 2.16B | -16.42% | 5,405,763 | 2.81B |
| 248 | LKFT | Lakefront Biotherapeutics NV | 2.15B | -0.98% | 123,187 | 1.13B |
| 249 | BHVN | Biohaven Ltd. | 2.13B | 1.33% | 253,625 | - |
| 250 | NEO | NeoGenomics, Inc. | 2.10B | -1.43% | 347,406 | 787.75M |
| 251 | TRLV | Trulieve Cannabis Corp. | 2.10B | - | 407,846 | 1.08B |
| 252 | ZYME | Zymeworks Inc. | 2.07B | 1.65% | 221,796 | 37.13M |
| 253 | FTRE | Fortrea Holdings Inc. | 2.06B | 4.40% | 626,912 | 2.67B |
| 254 | VIR | Vir Biotechnology, Inc. | 2.02B | 7.08% | 384,539 | 302.80M |
| 255 | PBH | Prestige Consumer Healthcare Inc. | 2.02B | -4.02% | 245,200 | 1.17B |
| 256 | TRAX | First Tracks Biotherapeutics, Inc. | 1.98B | 3.49% | 61,407 | - |
| 257 | TRVI | Trevi Therapeutics, Inc. | 1.97B | 7.96% | 448,308 | - |
| 258 | REPL | Replimune Group, Inc. | 1.97B | 3.70% | 793,593 | - |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 1.95B | 2.22% | 175,490 | 989.36M |
| 260 | ESTA | Establishment Labs Holdings Inc. | 1.95B | 1.49% | 74,130 | 264.03M |
| 261 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.93B | -1.38% | 866,225 | 961.51M |
| 262 | VCYT | Veracyte, Inc. | 1.92B | -0.23% | 2,582,963 | 581.78M |
| 263 | XRAY | DENTSPLY SIRONA Inc. | 1.90B | -5.40% | 4,282,924 | 3.58B |
| 264 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.90B | 4.58% | 493,196 | 213.00M |
| 265 | SRPT | Sarepta Therapeutics, Inc. | 1.89B | 1.82% | 523,001 | 1.96B |
| 266 | INSP | Inspire Medical Systems, Inc. | 1.86B | -3.31% | 90,651 | 880.94M |
| 267 | MAZE | Maze Therapeutics, Inc. | 1.86B | 6.12% | 95,030 | 20.00M |
| 268 | ALMR | Alamar Biosciences, Inc. | 1.85B | -0.84% | 201,077 | 114.05M |
| 269 | LMAT | LeMaitre Vascular, Inc. | 1.85B | -3.20% | 80,305 | 269.36M |
| 270 | CERT | Certara, Inc. | 1.84B | -1.07% | 1,141,369 | 412.03M |
| 271 | MESO | Mesoblast Limited | 1.83B | -0.14% | 121,671 | 120.25M |
| 272 | AGL | agilon health, inc. | 1.82B | -4.63% | 60,627 | 6.00B |
| 273 | WGS | GeneDx Holdings Corp. | 1.79B | -6.52% | 226,820 | 454.43M |
| 274 | ZBIO | Zenas BioPharma, Inc. | 1.79B | 6.04% | 115,648 | 11.00M |
| 275 | LYCA | Lycia Therapeutics, Inc. | 1.76B | 5.89% | 146,011 | 4.44M |
| 276 | NVAX | Novavax, Inc. | 1.76B | 8.90% | 2,325,122 | 411.65M |
| 277 | AGIO | Agios Pharmaceuticals, Inc. | 1.75B | 3.54% | 292,289 | 140.84M |
| 278 | ALVO | Alvotech | 1.73B | 6.48% | 362,161 | 494.61M |
| 279 | OMCL | Omnicell, Inc. | 1.73B | -1.26% | 104,308 | 1.24B |
| 280 | STOK | Stoke Therapeutics, Inc. | 1.71B | 0.54% | 234,898 | 28.21M |
| 281 | KMTS | Kestra Medical Technologies, Ltd. | 1.70B | 0.07% | 47,780 | 106.73M |
| 282 | PSNL | Personalis, Inc. | 1.70B | 0.58% | 1,324,701 | 80.77M |
| 283 | AZTA | Azenta, Inc. | 1.69B | 3.25% | 128,415 | 613.81M |
| 284 | ABSI | Absci Corporation | 1.67B | 3.51% | 891,276 | 1.56M |
| 285 | ASTH | Astrana Health, Inc. | 1.66B | -13.66% | 315,203 | 3.91B |
| 286 | NRIX | Nurix Therapeutics, Inc. | 1.66B | 2.43% | 930,194 | 701.94M |
| 287 | BFLY | Butterfly Network, Inc. | 1.65B | 1.65% | 951,743 | 123.26M |
| 288 | GENB | Generate Biomedicines, Inc. | 1.65B | 2.23% | 195,481 | 26.48M |
| 289 | KLRA | Kailera Therapeutics, Inc. | 1.65B | 4.44% | 66,206 | - |
| 290 | HCSG | Healthcare Services Group, Inc. | 1.64B | -3.07% | 111,116 | 1.88B |
| 291 | TDOC | Teladoc Health, Inc. | 1.64B | -4.46% | 1,623,112 | 2.47B |
| 292 | SLS | SELLAS Life Sciences Group, Inc. | 1.60B | 0.57% | 4,359,965 | - |
| 293 | RARE | Ultragenyx Pharmaceutical Inc. | 1.59B | 0.64% | 1,405,560 | 730.00M |
| 294 | ENOV | Enovis Corporation | 1.59B | -3.84% | 284,166 | 2.31B |
| 295 | NTLA | Intellia Therapeutics, Inc. | 1.56B | 0.18% | 1,445,969 | 52.89M |
| 296 | NBTX | Nanobiotix S.A. | 1.56B | - | 22,625 | 13.15M |
| 297 | CNMD | CONMED Corporation | 1.56B | -1.21% | 74,771 | 1.37B |
| 298 | ETON | Eton Pharmaceuticals, Inc. | 1.55B | 15.38% | 548,343 | 141.06M |
| 299 | IMCR | Immunocore Holdings plc | 1.54B | 5.32% | 383,356 | 430.78M |
| 300 | NVCR | NovoCure Limited | 1.54B | -2.80% | 232,905 | 725.39M |
| 301 | SNDA | Sonida Senior Living, Inc. | 1.54B | -5.17% | 416,132 | 593.38M |
| 302 | ALHC | Alignment Healthcare, Inc. | 1.52B | -4.23% | 976,566 | 4.94B |
| 303 | PGEN | Precigen, Inc. | 1.51B | 0.12% | 2,911,693 | 156.94M |
| 304 | USPH | U.S. Physical Therapy, Inc. | 1.49B | 2.53% | 77,892 | 829.86M |
| 305 | ANIP | ANI Pharmaceuticals, Inc. | 1.48B | -0.73% | 121,353 | 1.04B |
| 306 | TYRA | Tyra Biosciences, Inc. | 1.48B | 3.06% | 169,174 | - |
| 307 | ADRX | ADARx Pharmaceuticals, Inc. | 1.48B | -0.68% | 157,828 | 6.13M |
| 308 | OCUL | Ocular Therapeutix, Inc. | 1.47B | 4.20% | 446,274 | 52.06M |
| 309 | QURE | uniQure N.V. | 1.47B | 0.90% | 213,089 | 20.17M |
| 310 | NUVB | Nuvation Bio Inc. | 1.47B | -0.95% | 1,423,201 | 201.73M |
| 311 | BRVE | Braveheart Bio, Inc. | 1.46B | 2.44% | 238,754 | - |
| 312 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.03% | 108,792 | 743.30M |
| 313 | AMN | AMN Healthcare Services, Inc. | 1.44B | -21.66% | 671,100 | 3.52B |
| 314 | TSHA | Taysha Gene Therapies, Inc. | 1.42B | 6.60% | 830,544 | 5.49M |
| 315 | RAPP | Rapport Therapeutics, Inc. | 1.42B | 1.01% | 101,861 | 20.00M |
| 316 | KRSA | Korsana Biosciences, Inc. | 1.40B | 1.17% | 16,182 | - |
| 317 | AAPG | Ascentage Pharma Group International | 1.39B | 1.12% | 2,159 | 94.61M |
| 318 | DMRA | Damora Therapeutics, Inc. | 1.38B | 2.20% | 64,125 | - |
| 319 | PAHC | Phibro Animal Health Corporation | 1.38B | -3.90% | 67,620 | 1.54B |
| 320 | INVA | Innoviva, Inc. | 1.38B | 0.68% | 434,051 | 438.32M |
| 321 | ANAB | AnaptysBio, Inc. | 1.38B | 1.03% | 57,827 | 106.09M |
| 322 | GPCR | Structure Therapeutics Inc. | 1.36B | 0.16% | 429,345 | - |
| 323 | OPK | OPKO Health, Inc. | 1.36B | 4.00% | 1,888,155 | 654.10M |
| 324 | MLYS | Mineralys Therapeutics, Inc. | 1.35B | -0.33% | 228,279 | - |
| 325 | CRON | Cronos Group Inc. | 1.33B | -3.23% | 594,845 | 206.20M |
| 326 | PNTG | The Pennant Group, Inc. | 1.33B | -5.53% | 348,124 | 1.17B |
| 327 | KARD | Kardigan, Inc. | 1.33B | 2.31% | 81,296 | - |
| 328 | LBRX | LB Pharmaceuticals Inc | 1.30B | 5.93% | 81,881 | - |
| 329 | STAA | STAAR Surgical Company | 1.29B | -4.15% | 239,927 | 328.27M |
| 330 | GHRS | GH Research PLC | 1.28B | 1.38% | 59,407 | - |
| 331 | LMRI | Lumexa Imaging Holdings, Inc. | 1.26B | -0.38% | 65,903 | 1.04B |
| 332 | NKTR | Nektar Therapeutics | 1.26B | 1.99% | 103,922 | 54.59M |
| 333 | MNKD | MannKind Corporation | 1.26B | 3.99% | 1,396,685 | 413.37M |
| 334 | DRTS | Alpha Tau Medical Ltd. | 1.25B | 1.95% | 94,939 | - |
| 335 | OMER | Omeros Corporation | 1.24B | 0.59% | 300,547 | 38.42M |
| 336 | NUTX | Nutex Health Inc. | 1.24B | -6.73% | 66,752 | 796.53M |
| 337 | AVLN | Avalyn Pharma Inc. | 1.24B | 4.48% | 58,517 | - |
| 338 | URGN | UroGen Pharma Ltd. | 1.23B | -2.33% | 411,172 | 250.25M |
| 339 | INNV | InnovAge Holding Corp. | 1.22B | -1.38% | 388,970 | 1.02B |
| 340 | SVRA | Savara Inc. | 1.21B | 9.13% | 673,774 | - |
| 341 | INBX | Inhibrx Biosciences, Inc. | 1.21B | 2.49% | 47,218 | 1.30M |
| 342 | GDRX | GoodRx Holdings, Inc. | 1.20B | 0.86% | 325,317 | 785.23M |
| 343 | VOR | Vor Biopharma Inc. | 1.19B | 3.91% | 117,912 | - |
| 344 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.19B | 1.16% | 249,973 | 745.79M |
| 345 | SLN | Silence Therapeutics plc | 1.19B | 0.18% | 136,280 | 615.00K |
| 346 | AHG | Akso Health Group | 1.17B | 5.02% | 1,971 | 13.83M |
| 347 | TNDM | Tandem Diabetes Care, Inc. | 1.16B | -6.95% | 2,182,170 | 1.08B |
| 348 | SGP | SpyGlass Pharma, Inc. | 1.16B | 1.69% | 46,980 | - |
| 349 | CMPS | COMPASS Pathways plc | 1.16B | 7.11% | 875,328 | - |
| 350 | ATEC | Alphatec Holdings, Inc. | 1.15B | -5.00% | 575,949 | 839.72M |
| 351 | PRCT | PROCEPT BioRobotics Corporation | 1.15B | -1.63% | 312,745 | 352.31M |
| 352 | SPTX | Seaport Therapeutics, Inc. | 1.13B | 3.53% | 49,542 | - |
| 353 | FRNM | Freenome, Inc. | 1.11B | -1.43% | 654,272 | 35.41M |
| 354 | IART | Integra LifeSciences Holdings Corporation | 1.09B | -0.96% | 82,069 | 1.66B |
| 355 | SIBN | SI-BONE, Inc. | 1.08B | -1.15% | 128,158 | 220.65M |
| 356 | IRMD | IRADIMED CORPORATION | 1.08B | -1.27% | 30,712 | 89.34M |
| 357 | JANX | Janux Therapeutics, Inc. | 1.03B | 4.89% | 155,128 | 23.29M |
| 358 | CBLL | CeriBell, Inc. | 1.02B | 1.19% | 90,658 | 108.72M |
| 359 | CSTL | Castle Biosciences, Inc. | 997.90M | -4.49% | 251,700 | 377.13M |
| 360 | AORT | Artivion, Inc. | 995.11M | -19.42% | 748,624 | 481.88M |
| 361 | VSTM | Verastem, Inc. | 992.66M | -12.90% | 3,475,962 | 100.30M |
| 362 | AHCO | AdaptHealth Corp. | 983.22M | -0.67% | 475,319 | 3.44B |
| 363 | HROW | Harrow, Inc. | 976.93M | 0.08% | 142,720 | 275.59M |
| 364 | MLTX | MoonLake Immunotherapeutics | 958.30M | 4.26% | 362,580 | - |
| 365 | GMRS | GMR Solutions Inc. | 954.42M | -1.84% | 111,154 | 5.88B |
| 366 | OMDA | Omada Health, Inc. | 949.16M | -18.18% | 1,673,169 | 333.04M |
| 367 | JBIO | Jade Biosciences, Inc. | 940.92M | 4.93% | 131,484 | - |
| 368 | IVA | Inventiva S.A. | 931.42M | 4.55% | 617,185 | 2.81M |
| 369 | ODTX | Odyssey Therapeutics, Inc. | 907.52M | 0.26% | 254,109 | 99.00K |
| 370 | ANRO | Alto Neuroscience, Inc. | 900.21M | 4.89% | 154,665 | - |
| 371 | ORIC | ORIC Pharmaceuticals, Inc. | 894.52M | 1.65% | 90,611 | - |
| 372 | HSTM | HealthStream, Inc. | 891.87M | -1.52% | 45,899 | 327.95M |
| 373 | CTY | City Therapeutics, Inc. | 886.42M | 4.36% | 29,124 | 14.34M |
| 374 | CRVS | Corvus Pharmaceuticals, Inc. | 877.38M | 7.19% | 222,248 | - |
| 375 | SNDX | Syndax Pharmaceuticals, Inc. | 876.88M | 3.95% | 1,077,781 | 289.68M |
| 376 | PHAR | Pharming Group N.V. | 875.77M | -0.49% | 4,347 | 386.75M |
| 377 | BVS | Bioventus Inc. | 872.94M | -3.00% | 141,421 | 585.64M |
| 378 | AKTS | Aktis Oncology, Inc. | 872.11M | 5.59% | 70,786 | 10.06M |
| 379 | GLUE | Monte Rosa Therapeutics, Inc. | 854.84M | -2.24% | 186,328 | 70.33M |
| 380 | IMTX | Immatics N.V. | 852.95M | 0.97% | 154,892 | 47.65M |
| 381 | MGTX | MeiraGTx Holdings plc | 852.86M | 4.35% | 185,667 | 397.50M |
| 382 | LTGO | Latigo Biotherapeutics, Inc. | 834.38M | -3.27% | 182,972 | - |
| 383 | KIDS | OrthoPediatrics Corp. | 814.65M | -3.17% | 45,418 | 264.14M |
| 384 | PRME | Prime Medicine, Inc. | 807.69M | 2.02% | 971,480 | 4.07M |
| 385 | BBNX | Beta Bionics, Inc. | 807.35M | -4.13% | 256,171 | 127.27M |
| 386 | QDEL | QuidelOrtho Corporation | 800.02M | -9.19% | 500,530 | 2.59B |
| 387 | BBTX | Bambusa Therapeutics, Inc. | 796.74M | -1.32% | 60,826 | - |
| 388 | COLL | Collegium Pharmaceutical, Inc. | 793.71M | -3.10% | 137,794 | 815.19M |
| 389 | ANNX | Annexon, Inc. | 792.44M | 4.37% | 1,156,256 | - |
| 390 | VREX | Varex Imaging Corporation | 777.84M | 0.08% | 143,081 | 865.00M |
| 391 | PHR | Phreesia, Inc. | 777.13M | -1.49% | 105,420 | 507.79M |
| 392 | ALMS | Alumis Inc. | 774.67M | 2.31% | 264,790 | 7.40M |
| 393 | INMD | InMode Ltd. | 767.08M | -0.41% | 167,136 | 374.63M |
| 394 | LXRX | Lexicon Pharmaceuticals, Inc. | 756.43M | 5.59% | 885,508 | 38.54M |
| 395 | RIGL | Rigel Pharmaceuticals, Inc. | 743.46M | -12.93% | 347,141 | 288.21M |
| 396 | SLDB | Solid Biosciences Inc. | 742.21M | 7.61% | 424,860 | - |
| 397 | ARDX | Ardelyx, Inc. | 741.55M | -1.34% | 1,804,174 | 468.22M |
| 398 | CTKB | Cytek Biosciences, Inc. | 740.82M | 4.91% | 213,830 | 207.65M |
| 399 | OABI | OmniAb, Inc. | 735.87M | 4.45% | 205,348 | 40.21M |
| 400 | ABUS | Arbutus Biopharma Corporation | 730.06M | 0.54% | 492,376 | 181.72M |
| 401 | DNA | Ginkgo Bioworks Holdings, Inc. | 729.30M | 8.73% | 1,182,388 | 130.75M |
| 402 | CGEM | Cullinan Therapeutics, Inc. | 727.21M | 4.63% | 178,683 | - |
| 403 | OBX | Obsidian Therapeutics, Inc. | 720.27M | 21.46% | 206,871 | - |
| 404 | IRWD | Ironwood Pharmaceuticals, Inc. | 712.18M | 6.95% | 1,476,535 | 400.30M |
| 405 | SANA | Sana Biotechnology, Inc. | 709.48M | 1.28% | 564,812 | - |
| 406 | PACB | Pacific Biosciences of California, Inc. | 702.48M | -7.00% | 3,208,580 | 161.39M |
| 407 | ATTO | Attovia Therapeutics, Inc. | 698.92M | 2.07% | 22,587 | 1.80M |
| 408 | AURA | Aura Biosciences, Inc. | 683.41M | 3.94% | 50,958 | - |
| 409 | NVCT | Nuvectis Pharma, Inc. | 683.12M | 9.80% | 19,231 | - |
| 410 | SGMT | Sagimet Biosciences Inc. | 674.34M | 4.28% | 253,679 | - |
| 411 | FDMT | 4D Molecular Therapeutics, Inc. | 671.77M | 8.09% | 210,755 | 92.01M |
| 412 | ZVRA | Zevra Therapeutics, Inc. | 670.02M | 6.93% | 575,485 | 147.76M |
| 413 | ACHV | Achieve Life Sciences, Inc. | 667.84M | 1.80% | 355,833 | - |
| 414 | HELP | Helus Pharma Inc. | 663.39M | 8.22% | 344,428 | - |
| 415 | WVE | Wave Life Sciences, Inc. | 660.72M | 4.04% | 542,862 | 70.92M |
| 416 | CADL | Candel Therapeutics, Inc. | 651.94M | 5.97% | 250,667 | - |
| 417 | GERN | Geron Corporation | 640.82M | 4.69% | 3,342,287 | 217.52M |
| 418 | KURA | Kura Oncology, Inc. | 639.63M | 5.74% | 1,110,165 | 77.23M |
| 419 | DSGN | Design Therapeutics, Inc. | 639.58M | 5.69% | 100,126 | - |
| 420 | IMMX | Immix Biopharma, Inc. | 631.72M | 5.83% | 304,884 | - |
| 421 | AVBP | ArriVent BioPharma, Inc. | 627.19M | 4.01% | 344,275 | - |
| 422 | DBVT | DBV Technologies S.A. | 622.91M | 1.94% | 20,598 | 3.74M |
| 423 | FLGT | Fulgent Genetics, Inc. | 617.17M | 18.38% | 212,247 | 330.28M |
| 424 | ANL | Adlai Nortye Group Ltd. | 614.36M | -1.45% | 21,243 | 18.06M |
| 425 | OLMA | Olema Pharmaceuticals, Inc. | 613.36M | 3.70% | 310,573 | - |
| 426 | APMD | Apnimed, Inc. | 609.06M | 3.32% | 44,582 | 115.12M |
| 427 | ACRS | Aclaris Therapeutics, Inc. | 602.89M | 7.76% | 415,257 | 6.40M |
| 428 | EVO | Evotec SE | 590.74M | -4.22% | 49,832 | 815.72M |
| 429 | SOPH | SOPHiA GENETICS SA | 584.19M | 3.02% | 131,247 | 90.97M |
| 430 | TCMD | Tactile Systems Technology, Inc. | 582.66M | -1.37% | 45,350 | 356.42M |
| 431 | BCAX | Bicara Therapeutics Inc. | 581.00M | 7.20% | 185,248 | - |
| 432 | MYGN | Myriad Genetics, Inc. | 578.03M | -3.97% | 488,826 | 803.60M |
| 433 | SLBT | SL Science Holding Limited | 559.03M | 8.91% | 9,472 | 3.27M |
| 434 | CBIO | Crescent Biopharma, Inc. | 555.13M | 0.23% | 9,794 | 11.88M |
| 435 | CLYM | Climb Bio, Inc. | 554.83M | 8.91% | 202,724 | - |
| 436 | AVR | Anteris Technologies Global Corp. | 553.76M | 1.79% | 568,467 | 2.24M |
| 437 | OVID | Ovid Therapeutics Inc. | 548.79M | 8.91% | 648,413 | 1.58M |
| 438 | SGHT | Sight Sciences, Inc. | 545.79M | 0.61% | 124,004 | 88.40M |
| 439 | NRC | NRC Health | 543.27M | 0.47% | 16,269 | 143.79M |
| 440 | VALN | Valneva SE | 543.01M | -0.18% | 3,137 | 163.30M |
| 441 | FTH | Faeth Therapeutics, Inc. | 534.12M | 3.77% | 143,123 | - |
| 442 | ENTX | Entera Bio Ltd. | 532.20M | 2.34% | 18,184 | 42.00K |
| 443 | NGNE | Neurogene Inc. | 532.10M | 3.66% | 117,617 | 925.00K |
| 444 | SRZN | Surrozen, Inc. | 527.13M | 3.90% | 8,961 | 11.51M |
| 445 | INDP | Indaptus Therapeutics, Inc. | 517.57M | 6.65% | 163,524 | - |
| 446 | EVH | Evolent Health, Inc. | 511.80M | -0.33% | 691,918 | 2.34B |
| 447 | RGNX | REGENXBIO Inc. | 511.60M | 5.01% | 248,070 | 153.91M |
| 448 | DCTH | Delcath Systems, Inc. | 511.11M | 1.66% | 141,347 | 95.42M |
| 449 | CAPR | Capricor Therapeutics, Inc. | 506.39M | 1.28% | 1,472,590 | 11.13M |
| 450 | MCTA | Charming Medical Limited | 504.26M | 6.75% | 4,251,392 | 4.81M |
| 451 | RCEL | AVITA Medical, Inc. | 503.80M | 3.89% | 448,087 | 75.63M |
| 452 | DMAC | DiaMedica Therapeutics Inc. | 502.59M | 3.10% | 53,133 | - |
| 453 | ANGO | AngioDynamics, Inc. | 494.14M | -0.51% | 43,656 | 325.38M |
| 454 | TKNO | Alpha Teknova, Inc. | 489.61M | 0.70% | 127,626 | 45.95M |
| 455 | SRTA | Strata Critical Medical, Inc. | 486.79M | 3.61% | 310,736 | 280.76M |
| 456 | MDXG | MiMedx Group, Inc. | 485.93M | 1.52% | 234,716 | 303.73M |
| 457 | GYRE | Gyre Therapeutics, Inc. | 477.15M | 12.22% | 150,313 | 110.06M |
| 458 | CTMX | CytomX Therapeutics, Inc. | 475.02M | 1.87% | 814,160 | 14.03M |
| 459 | ETRA | Electra Therapeutics, Inc. | 470.12M | 1.90% | 109,860 | - |
| 460 | STTK | Shattuck Labs, Inc. | 469.70M | 4.23% | 325,494 | 1.00M |
| 461 | IAM | Iambic Therapeutics, Inc. | 465.48M | -15.64% | 257,881 | 18.25M |
| 462 | MNPR | Monopar Therapeutics Inc. | 463.61M | 2.75% | 45,931 | - |
| 463 | BWAY | BrainsWay Ltd. | 458.47M | 3.96% | 45,709 | 60.70M |
| 464 | AQST | Aquestive Therapeutics, Inc. | 458.13M | -0.41% | 1,053,520 | 48.84M |
| 465 | STLN | Starling Oncology, Inc. | 457.60M | -32.99% | 6,126,658 | 620.45M |
| 466 | SSII | SS Innovations International, Inc. | 450.87M | 18.42% | 44,274 | 52.40M |
| 467 | YDES | YD Bio Limited | 449.78M | -11.56% | 53,985 | 1.24M |
| 468 | EOLS | Evolus, Inc. | 446.46M | -0.66% | 213,760 | 325.47M |
| 469 | OCS | Oculis Holding AG | 446.01M | 5.78% | 94,726 | 1.12M |
| 470 | EPRX | Eupraxia Pharmaceuticals Inc. | 443.32M | 1.97% | 295,360 | - |
| 471 | MASS | 908 Devices Inc. | 434.83M | 3.65% | 88,336 | 60.84M |
| 472 | NPCE | NeuroPace, Inc. | 426.65M | -2.05% | 54,314 | 106.99M |
| 473 | SENS | Senseonics Holdings, Inc. | 422.46M | - | 264,671 | 48.55M |
| 474 | ARVN | Arvinas, Inc. | 421.07M | -1.83% | 349,427 | 275.30M |
| 475 | ASMB | Assembly Biosciences, Inc. | 415.36M | 2.00% | 27,189 | 74.85M |
| 476 | PRTA | Prothena Corporation plc | 415.32M | 2.53% | 109,385 | 52.74M |
| 477 | CERS | Cerus Corporation | 415.02M | -3.52% | 549,410 | 226.57M |
| 478 | BLSM | BlossomHill Therapeutics, Inc. | 414.16M | 5.51% | 38,777 | - |
| 479 | SI | Shoulder Innovations, Inc. | 411.80M | -2.90% | 38,097 | 64.49M |
| 480 | RLMD | Relmada Therapeutics, Inc. | 409.61M | 1.86% | 278,908 | - |
| 481 | PBYI | Puma Biotechnology, Inc. | 407.28M | -19.24% | 553,150 | 231.87M |
| 482 | KMDA | Kamada Ltd. | 407.13M | 4.51% | 47,199 | 191.85M |
| 483 | TLRY | Tilray Brands, Inc. | 406.99M | -1.25% | 1,659,925 | 963.10M |
| 484 | PHAT | Phathom Pharmaceuticals, Inc. | 406.68M | 0.79% | 440,582 | 274.88M |
| 485 | CRMD | CorMedix Inc. | 399.85M | -1.91% | 561,717 | 462.25M |
| 486 | AGMB | AgomAb Therapeutics NV | 392.01M | 14.20% | 19,230 | - |
| 487 | ALT | Altimmune, Inc. | 390.98M | 2.03% | 910,458 | 31.00K |
| 488 | TECX | Tectonic Therapeutic, Inc. | 390.69M | 2.91% | 34,140 | - |
| 489 | RZLT | Rezolute, Inc. | 390.22M | 2.20% | 390,192 | - |
| 490 | ZURA | Zura Bio Limited | 387.71M | 8.20% | 547,216 | - |
| 491 | EDIT | Editas Medicine, Inc. | 385.49M | -1.57% | 899,743 | 47.01M |
| 492 | CARL | Carlsmed, Inc. | 382.51M | -8.55% | 30,606 | 63.30M |
| 493 | TRXB | TRex Bio, Inc. | 376.37M | 7.62% | 65,325 | - |
| 494 | LYEL | Lyell Immunopharma, Inc. | 375.91M | 1.93% | 89,106 | 15.00K |
| 495 | CCCC | C4 Therapeutics, Inc. | 367.23M | 1.19% | 366,345 | 32.28M |
| 496 | CTNM | Contineum Therapeutics, Inc. | 365.17M | 5.56% | 98,291 | - |
| 497 | MOBI | Mobia Medical, Inc. | 364.54M | -2.93% | 87,073 | 51.89M |
| 498 | PRLD | Prelude Therapeutics Incorporated | 359.45M | -1.83% | 52,676 | 22.42M |
| 499 | AVTX | Avalo Therapeutics, Inc. | 359.32M | 1.06% | 216,501 | 59.00K |
| 500 | CTEV | Claritev Corporation | 358.86M | 4.72% | 29,118 | 994.67M |